A252 LONG-TERM OUTCOMES IN INFLAMMATORY BOWEL DISEASE PATIENTS WITH PRIMARY SCLEROSING CHOLANGITIS: KINGSTON HEALTH SCIENCES CENTER LOCAL EXPERIENCE

BACKGROUND: IBD-PSC remains a poorly understood entity due to it’s low incidence and the heterogeneity found within this patient population. Patients with IBD-PSC have 0.3-2.8% lifetime risk of developing hepatocellular carcinoma, up to a 20% lifetime risk of developing Cholangiocarcinoma and a 20-3...

Descripción completa

Detalles Bibliográficos
Autores principales: Greenblatt, M, Mulder, D, Flemming, J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Poster Presentations
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9991255/
http://dx.doi.org/10.1093/jcag/gwac036.252

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9991255/
http://dx.doi.org/10.1093/jcag/gwac036.252

Ejemplares similares